4//SEC Filing
Hoffman Reid 4
Accession 0002050755-25-000011
CIK 0001817229other
Filed
Oct 7, 8:00 PM ET
Accepted
Oct 8, 5:20 PM ET
Size
13.1 KB
Accession
0002050755-25-000011
Insider Transaction Report
Form 4
Reprogrammed Interchange LLC
10% Owner
Transactions
- Sale
Common Stock
2025-10-06$37.77/sh−18,156$685,830→ 1,526,545 total - Sale
Common Stock
2025-10-07$33.84/sh−27,624$934,711→ 1,498,921 total - Sale
Common Stock
2025-10-06$36.00/sh−17,760$639,392→ 1,579,548 total - Sale
Common Stock
2025-10-06$37.12/sh−34,847$1,293,566→ 1,544,701 total
Hoffman Reid
10% Owner
Transactions
- Sale
Common Stock
2025-10-07$33.84/sh−27,624$934,711→ 1,498,921 total - Sale
Common Stock
2025-10-06$37.12/sh−34,847$1,293,566→ 1,544,701 total - Sale
Common Stock
2025-10-06$36.00/sh−17,760$639,392→ 1,579,548 total - Sale
Common Stock
2025-10-06$37.77/sh−18,156$685,830→ 1,526,545 total
Footnotes (5)
- [F1]This transaction was executed in multiple trades at prices ranging from $35.59 to $36.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F2]The securities are held by Reprogrammed Interchange LLC ("Reprogrammed"). Reid Hoffman may be deemed a beneficial owner of securities held by Reprogrammed by virtue of his shared control over and indirect pecuniary interest in Reprogrammed. Mr. Hoffman disclaims beneficial ownership of the securities held by Reprogrammed, except to the extent of his pecuniary interest therein.
- [F3]This transaction was executed in multiple trades at prices ranging from $36.59 to $37.58. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F4]This transaction was executed in multiple trades at prices ranging from $37.59 to $38.18 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
- [F5]This transaction was executed in multiple trades at prices ranging from $33.70 to $34.27. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001519339
Filing Metadata
- Form type
- 4
- Filed
- Oct 7, 8:00 PM ET
- Accepted
- Oct 8, 5:20 PM ET
- Size
- 13.1 KB